About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 622 record(s)
Req # A-2023-001202
Adverse Drug Reactions (ADRs) for Abilify Maintena, Aripiprazole. Report numbers: 001065912, 001069455, E2B_06655775, E2B_06662846. ADRs for Sucroferric oxyhydroxide. Report numbers: E2B_06595703, E2B_06620171, E2B_06620172, E2B_06657227,…Organization: Health Canada
March 2024
Req # A-2023-001211
Adverse Drug Reactions (ADRs) for Lansoprazole. Report numbers: E2B_06701592, E2B_06688522, E2B_06690949, E2B_06686903, 001068701, 001064552.Organization: Health Canada
March 2024
Req # A-2023-001218
Adverse Drug Reactions (ADRs). Report numbers: 001056376, E2B_06602443, E2B_06597136, E2B_06636224, E2B_06624489, E2B_06665895, 001008281.Organization: Health Canada
March 2024
Req # A-2023-001224
Adverse Drug Reaction (ADR). Report number: E2B_06648009.Organization: Health Canada
March 2024
Req # A-2023-001228
Adverse Drug Reactions (ADRs). Report numbers: 001029011, 001032323.Organization: Health Canada
March 2024
Req # A-2023-001248
Adverse Drug Reactions (ADRs). Report numbers: 001066645, E2B_06652773, E2B_06652035, E2B_06667006, E2B_06658740, E2B_06696430.Organization: Health Canada
March 2024
Req # A-2023-001251
Adverse Drug Reactions (ADRs). Report numbers: E2B_06237597, E2B_06249123, E2B_01569944, 1033939, E2B_06276132, E2B_06276260, E2B_06320663, E2B_06320721, 1037986, E2B_06332106.Organization: Health Canada
March 2024
Req # A-2023-001252
Adverse Drug Reactions (ADRs). Report numbers: E2B_06372261, E2B_06377856, 1050131, 1049743, E2B_06339982, 1042341, 1048640, 1038544, E2B_06399744, E2B_06428505.Organization: Health Canada
March 2024
Req # A-2023-001255
Adverse Drug Reactions (ADRs). Report numbers: E2B_06659829, E2B_06626329.Organization: Health Canada
March 2024
Req # A-2023-001278
Adverse Drug Reaction (ADR). Report number: E2B_06662052.Organization: Health Canada
March 2024